Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290

Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice

Soriano, P. M., Montgomery, C. A., Geske, R. S., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 1,997

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789

In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria.

Sudo, H., Kodama, H. A., Amagai, Y., Yamamoto, S., & Kasai, S. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.96.1.191 · Cited by 1,673

Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of Osteoporosis

Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,670

c-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone Remodeling

Grigoriadis, A. E., Wang, Z., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A., & Wagner, E. F. (1994) · Science · doi:10.1126/science.7939685 · Cited by 1,264

Protective Effect of Amlodipine on Rat Bone Tissue after Orchidectomy

Gradošová, I., Živná, H., Palička, V., Hubená, S., Švejkovská, K., & Živný, P. (2012) · Pharmacology · doi:10.1159/000335491 · Cited by 17

Suppressive effects of Anoectochilus formosanus extract on osteoclast formation in vitro and bone resorption in vivo

Masuda, K., Ikeuchi, M., Koyama, T., Yamaguchi, K., Woo, J.-T., Nishimura, T., & Yazawa, K. (2008) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0810-8 · Cited by 18

Osteoclast: Origin and Differentiation

Rubin, J. E., & Greenfield, E. M. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_1 · Cited by 18

Engineering the bone metastatic prostate cancer niche through a microphysiological system to report patient-specific treatment response

Sánchez‐de‐Diego, C., Yada, R. C., Sethakorn, N., Geiger, P. G., Ding, A. B., Héninger, E., Ahmed, F., Virumbrales-Muñoz, M., Lupsa, N., Bartels, E., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08384-2 · Cited by 18

Response of a Preosteoblastic Cell Line to Cyclic Tensile Stress Conditioning and Growth Factors for Bone Tissue Engineering

Chung, E., & Rylander, M. N. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0414 · Cited by 16

Pathogenesis of Myelofibrosis With Myeloid Metaplasia: Lessons From Mouse Models of the Disease

Vannucchi, A. M. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.04.008 · Cited by 16

Corticosteroid-Induced Osteoporosis

Clarke, B. L. (2012) · American Journal of Clinical Dermatology · doi:10.2165/11594250-000000000-00000 · Cited by 16

Involvement of p38MAP kinase in bone morphogenetic protein-4-induced osteoprotegerin in mouse bone-marrow-derived stromal cells

Tazoe, M., Mogi, M., Goto, S., & Togari, A. (2003) · Archives of Oral Biology · doi:10.1016/s0003-9969(03)00100-6 · Cited by 16

Janus kinase inhibitors role in bone remodeling

Maruotti, N., Corrado, A., Rotondo, C., & Cantatore, F. P. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29149 · Cited by 15

Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models

Chagraoui, H., Wendling, F., & Vainchenker, W. (2006) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2005.07.002 · Cited by 15

Dexamethasone inhibits bone resorption by indirectly inducing apoptosis of the bone-resorbing osteoclasts via the action of osteoblastic cells

蕨, 信., Tachibana, Y., Kumegawa, M., & Hakeda, Y. (2001) · Cytotechnology · doi:10.1023/a:1008159332152 · Cited by 14

The impact of forced swimming on expression of RANKL and OPG in a type 2 diabetes mellitus rat model

Pezhman, L., Hesari, F. S., Ghiasi, R., & Alipour, M. R. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1446178 · Cited by 15

Relationships of a Transforming Growth Factor-β2 Single Nucleotide Polymorphism and Messenger Ribonucleic Acid Abundance with Bone and Production Traits in Chickens

Bennett, A. K., Hester, P. Y., & Spurlock, D. M. (2007) · Poultry Science · doi:10.1093/ps/86.5.829 · Cited by 13

Basic Fibroblast Growth Factor Inhibits Osteoclast Formation Induced by 1α,25-Dihydroxyvitamin D3 through Suppressing the Production of Osteoclast Differentiation Factor

Nakagawa, N., Yasuda, H., Yano, K., Mochizuki, S.-I., Kobayashi, N., Fujimoto, H., Yamaguchi, K., Shima, N., Morinaga, T., & Higashio, K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1621 · Cited by 13

Direct and indirect effects of transforming growth factor-beta on osteoclast-mediated bone remodeling using a new in vitro bone matrix model

Chiba-Ohkuma, R., Karakida, T., Yamamoto, R., & Yamakoshi, Y. (2025) · JBMR Plus · doi:10.1093/jbmrpl/ziaf104 · Cited by 12

The early phase response of rat alveolar bone to traumatic occlusion

Wan, H., Sun, H. Q., Sun, G.-X., Li, X., & Shang, Z. (2012) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2012.01.002 · Cited by 12

Osteoprotegerin and Bone Mass in Squamous Cell Head and Neck Cancer Patients

Valero, C., Olmos, J. M., Rivera, F., Hernández, J. L., Vega, M. E., & Macías, J. G. (2006) · Calcified Tissue International · doi:10.1007/s00223-005-0237-y · Cited by 12

Protein Kinase C Is a Mediator of the Synthesis and Secretion of Osteoprotegerin in Osteoblast-like Cells

Yang, X., Halladay, D., Onyia, J. E., Martin, T. J., & Chandrasekhar, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6176 · Cited by 12

Mechanisms involved in suppression of osteoclast supportive activity by transforming growth factor-β1 via the ubiquitin-proteasome system

Inoue, M., Nagai‐Yoshioka, Y., Yamasaki, R., Kawamoto, T., Nishihara, T., & Ariyoshi, W. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262612 · Cited by 11

Apoptosis in Bone Cells

Boyce, B. F., Xing, L., Jilka, R. L., Bellido, T., Weinstein, R. S., PARFITT, A. M., & Manolagas, S. C. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50112-8 · Cited by 21

Signaling Pathways in Root Resorption: Linking Inflammation, Odontoclastogenesis, and Tissue Remodeling

Rostami, G., Siddappa, R. H. R., & Kishen, A. (2025) · Journal of Endodontics · doi:10.1016/j.joen.2025.08.018 · Cited by 12

Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor

Rzepka, R., Dołęgowska, B., Sałata, D., Rajewska, A., Budkowska, M., Domański, L., Kwiatkowski, S., Mikołajek-Bedner, W., & Torbè, A. (2015) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-015-0559-3 · Cited by 10

TGF-β in jaw tumor fluids induces RANKL expression in stromal fibroblasts

Yamada, C., Aikawa, T., Okuno, E., Miyagawa, K., Amano, K., Takahata, S., Kimata, M., Okura, M., Iida, S., & Kogo, M. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3548 · Cited by 10

Relationship between age-related serum concentrations of TGF-β1 and TGF-β2 and those of osteoprotegerin and leptin in native Chinese women

Zhang, N., Wu, X., Wu, X., Fu, X., Du, X.-Y., Xie, H., Peng, Y., Luo, X., & Liao, E.-Y. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.01.021 · Cited by 10

Postmenopausal Osteoporosis

Pacifici, R. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50042-8 · Cited by 10

Estrogens and Progestins

Rickard, D. G., Harris, S. A., TURNER, R., Khosla, S., & Spelsberg, T. C. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50139-6 · Cited by 10

Osteoprotegerin expression and serum values in obese women with type 2 diabetes mellitus

Rashad, N. M., El‐Shal, A. S., Shalaby, S. M., Abdelnour, H. M., & Sarhan, W. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06699-x · Cited by 9

PDGF BB purified from osteoclasts acts as osteoblastogenesis inhibitory factor (OBIF).

Kubota, K., Sakikawa, C., Katsumata, M., Nakamura, T., & Wakabayashi, K. (2002) · PubMed Central · Cited by 9

Proteomics approach to identify novel metastatic bone markers from the secretome of PC‐3 prostate cancer cells

Sung, E., Kwon, O. K., Lee, J., & Lee, S. (2017) · Electrophoresis · doi:10.1002/elps.201700052 · Cited by 9

Mechanisms of Estrogen Action in Bone

Pacifici, R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00059-8 · Cited by 9

Association of SMAD2 polymorphisms with bone mineral density in postmenopausal Korean women

Kim, B., Hwang, J. Y., Han, B. G., Lee, J., Lee, J., Park, E. K., Lee, S. H., Chung, Y. E., Kim, G. S., Kim, S.-Y., et al. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1450-8 · Cited by 8

Anabolic effects of a G protein–coupled receptor kinase inhibitor expressed in osteoblasts

Spurney, R. F., Flannery, P. J., Garner, S. C., Athirakul, K., Liu, S., Guilak, F., & Quarles, L. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214663 · Cited by 8

TGF-β and Physiological Root Resorption of Deciduous Teeth

Shimazaki, E., Karakida, T., Yamamoto, R., Kobayashi, S., Fukae, M., Yamakoshi, Y., & Asada, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010049 · Cited by 8

Cytokines and Bone Remodeling

Mundy, G. R., Oyajobi, B. O., Traianedes, K., Dallas, S. L., & Chen, D. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50014-3 · Cited by 8

Osteoprotegerin: regulator, protector and marker

Othmane, T., Speer, G., Fekete, B., Szabó, T., Egresits, J., Fodor, E., Kiss, I., Nemcsik, J., Szabó, A., Németh, Z., et al. (2008) · Orvosi Hetilap · doi:10.1556/oh.2008.28470 · Cited by 7

An impulsive mathematical model of bone formation and resorption: effects of parathyroid hormone, calcitonin and impulsive estrogen supplement

Chaiya, I., & Rattanakul, C. (2017) · Advances in Difference Equations · doi:10.1186/s13662-017-1206-2 · Cited by 7

NF-κB Decoy ODN-Loaded Poly(Lactic-co-glycolic Acid) Nanospheres Inhibit Alveolar Ridge Resorption

Huang, A. C.-S., Ishida, Y., Li, K., Rintanalert, D., Hatano-sato, K., Oishi, S., Hosomichi, J., Usumi‐Fujita, R., Yamaguchi, H., Tsujimoto, H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043699 · Cited by 6

Prohibitins, novel vitamin K2 target factors in osteoblast

Uebi, T., Umeda, M., Maekawa, N., Karasawa, S., Handa, H., & Imai, T. (2013) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2013.13001 · Cited by 6

Enamel matrix derivative neutralized the effect of lipopolysaccharide on osteoprotegerin and receptor activator of nuclear factor kappa B ligand expression of osteoblasts

Wada, Y., Mizuno, M., & Tamura, M. (2009) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2009.01.004 · Cited by 6

High LDL levels lessen bone destruction during antigen-induced arthritis by inhibiting osteoclast formation and function

Ascone, G., Ceglie, I. D., Walgreen, B., Sloetjes, A. W., Lindhout, E., Bot, I., van de Loo, F. A. J., Koenders, M. I., van der Kraan, P. M., Blom, A. B., et al. (2019) · Bone · doi:10.1016/j.bone.2019.115140 · Cited by 6

Osteoprotegerin (OPG) Upregulation Activates Breast Stromal Fibroblasts and Enhances Their Pro-Carcinogenic Effects through the STAT3/IL-6 Signaling

Al-Nasrallah, H. K., Al‐Ansari, M. M., & Aboussekhra, A. (2022) · Cells · doi:10.3390/cells11213369 · Cited by 4

The Role of the Immune System in the Development of Osteoporosis

Mödder, U. I., Riggs, B. L., & Khosla, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10009-3 · Cited by 4

Skeletal Fragility in the Elderly

Inzerillo, A. M., Iqbal, J. Z., Troen, B. R., Meier, D. E., & Zaidi, M. (2006) · Springer eBooks · doi:10.1007/0-387-22621-4_44 · Cited by 4

The Effects of Adiponectin on Bone Metabolism

Lin, Y., Chen, C., Chen, C. C., Lin, H. J., Mersmann, H. J., Wu, S., & Ding, S. (2014) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2014.79062 · Cited by 3

Therapeutic and Preventive Effects of Osteoclastogenesis Inhibitory Factor on Osteolysis, Proliferation of Mammary Tumor Cell and Induction of Cancer Stem Cells in the Bone Microenvironment

Futakuchi, M., Nitanda, T., Ando, S., Matsumoto, H., Yoshimoto, E., Fukamachi, K., & Suzui, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030888 · Cited by 3

SMAD2/3 Phosphorylation is correlated with matrix metalloproteinase 9 expression in human periapical lesions

Wan, C., Wang, Y., Li, L., Liu, L., & Guan, Q. (2023) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2023.105796 · Cited by 3

How to get to the right place at the right time: Rab/Ypt small GTPases and vesicle transport

Ragnini‐Wilson, A. (1999) · PROTOPLASMA · doi:10.1007/bf01415697 · Cited by 3

Role of Matrix Metalloproteinases in Extracellular Matrix Disintegration of Meckel's Cartilage in Mice

Sakakura, Y. (2010) · Journal of Oral Biosciences · doi:10.1016/s1349-0079(10)80043-x · Cited by 3

Interaction of osteoprotegerin with fibulin-1 is essential for extracellular matrix deposition in fibrotic lung tissuePreprint

Liu, Y., Habibie, H., Borghuis, T., Liu, G., Hansbro, P. M., Melgert, B. N., & Burgess, J. K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.05.626371 · Cited by 3

The Changes in the Serum RANKL and OPG levels after Bone Marrow Transplantation: Association with Bone Mineral Metabolism

Tae, H. J., Baek, K., Oh, E.-S., Oh, K. W., Lee, W., Kim, H.-S., Han, J.-H., Cha, B. Y., Lee, K. W., Son, H., et al. (2005) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2005.20.1.40 · Cited by 1

Skeletal Health in Pediatric Inflammatory Bowel Disease

Sylvester, F. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-73481-1_11 · Cited by 2

The Role of Sex Steroids in the Effects of Immune System on Bone

Grčević, D., Kovačić, N., & Lee, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00012-8 · Cited by 2

Levels of TGF-β1 in peri-miniscrew implant crevicular fluid

Kaur, A., Kharbanda, O. P., Rajeswari, M. R., & Kalyanasundaram, D. (2020) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2020.03.002 · Cited by 2

Influence of osteoprotegerin (OPG) on experimentally induced ectopic bone

Włodarski, K. H., Kochanowska, I. E., Pieńkowski, M., & Ostrowski, K. (2004) · Folia Biologica · doi:10.3409/1734916044527520 · Cited by 2

Osteoclastogénesis y enfermedades óseas

Mikán, V. J. F., & Oliveros, A. W. D. (2007) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 2

Colony-Stimulating Factors

Hofstetter, W., & Gillespie, M. T. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50154-2 · Cited by 3

The Molecular Pharmacology of Osteoporosis

Iqbal, J. Z., Inzerillo, A. M., Moonga, B. S., & Zaidi, M. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-278-4_28 · Cited by 2

Regulation of RANKL-Induced Osteoclastogenesis by TGF-β

Yasui, T., Yasuda, H., & Tanaka, S. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5366-6_11 · Cited by 1

The Current Knowledge of Genetic Susceptibility Influencing Dental Implant Outcomes

Alvim‐Pereira, F., Cristina, C., & Cristina, P. (2011) · InTech eBooks · doi:10.5772/18065 · Cited by 1

Influence of Osteoprotegerin (OPG) on Resorption of Heterotopically Induced Ossicle

Kochanowska, I. E., Włodarski, K., Pienkowski, M. M., & Ostrowski, K. (2004) · Cell and Tissue Banking · doi:10.1023/b:catb.0000034095.83717.23 · Cited by 1

Cytokines and Bone Remodeling

Mundy, G. R., Oyajobi, B. O., Gutierrez, G., Sterling, J. A. R., Padalecki, S. S., Elefteriou, F., & Zhao, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50019-6 · Cited by 1

Hydrothermal Magnesium Alloy Extracts Modulate MicroRNA Expression in RAW264.7 Cells: Implications for Bone Remodeling

Costa, V., Raimondi, L., Bellavia, D., Luca, A. D., Guglielmi, P., Cusanno, A., Cattini, L., Pulsatelli, L., Pavarini, M., Chiesa, R., et al. (2025) · Journal of Functional Biomaterials · doi:10.3390/jfb16080303 · Cited by 1

Influence of the Bone Microenvironment on Breast Cancer Metastasis to Bone

Eckhardt, B. L., Pouliot, N., & Anderson, R. L. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_8 · Cited by 1

Interleukin-11

KEITHJR, J. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50019-3 · Cited by 1

Dendritic Cell-Associated Osteoclastogenesis and Bone Loss

Liu, Y.-C. G., & Teng, Y.-T. A. (2009) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9059-1 · Cited by 1

Osteokonduktion und Hydroxylapatitkeramiken

Soldner, E. H., Herr, G., Schnettler, R., & Börner, M. (2001) · Trauma und Berufskrankheit · doi:10.1007/s10039-001-0502-x · Cited by 1

The Role of Purinergic Signaling in the Interactions between Skeletal Cells

Gartland, A., Gallagher, J. A., & Buckley, K. (2006) · CRC Press eBooks · doi:10.1201/9780849333682.ch3 · Cited by 1

Receptor activator of nuclear factor кB ligand (RANKL) versus osteoprotegerin (OPG): the yin and yang of joint integrity

Bolon, B. N., Shalhoub, V., Kostenuik, P. J., Zack, D. J., & Feige, U. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7883-8_10

Bedeutung von RANK-Ligand und Osteoprotegerin für den Knochenstoffwechsel

Hofbauer, L. C., & Schoppet, M. (2006) · Springer eBooks · doi:10.1007/3-540-28782-5_21

An Agent-based Model for Evaluating Cellular Mechanisms of Bone Remodeling

Schutte, L. (2012) · KiltHub Repository · doi:10.1184/r1/6714668

Studies on the phenotype and function of osteoclasts using osteopetrotic and rachitic animal models

Hollberg, K. (2007) · Figshare

Osteogenetic growth factors around loosened hip replacements

Waris, V. J. (2014) · Työväentutkimus Vuosikirja

Cytokine regulation of bone destruction

Lubberts, E., & van den Berg, W. B. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7883-8_11

Osteoprotegerin: a pathological role in human abdominal aortic aneurysm

Moran, C. S. (2025) · ResearchOnline at James Cook University (James Cook University) · doi:10.25903/j9h2-9r90

Novel roles of bone lining cells in bone remodeling

Pérez‐Amodio, S. (2005)

Muscular Strength Training Modifies Regulation of Bone Remodeling: Inferences from Serum Biomarkers in Young Women

Mardock, M. A. (2003) · VTechWorks (Virginia Tech)

Acidosis, osteoclast formation and cathepsin K expression in the loosening of total hip prostheses

Mandelin, J. (2005) · Työväentutkimus Vuosikirja

Biomimetica per l'ingegneria tissutale dell'osso

Devescovi, V. (2008) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/705

Inflammatory Bowel Diseases and Skeletal Health

Sylvester, F. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5061-0_13

Mecanismos de calcificación vascular asociados a la uremia y al tratamiento con Calcitriol.

García, S. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

Differential contributions of host-derived matrix metalloproteinases in mammary tumor growth in the bone microenvironment

Thiolloy, S. (2009)

Rola RANK/RANKL i OPG w szpiczaku plazmocytowym* The role of RANK/RANKL and OPG in multiple myeloma

Kandefer‐Szerszeń, M. (2006)

Effects of Interleukin 11(IL-11) on the Experssion of RANK mRNA and Osteoclast Differentiation in a Human Myeloid Leukemia Cell Line(HL60).

Furuta, T. (2000) · Japanese Journal of Oral Biology · doi:10.2330/joralbiosci1965.42.121

New Approaches to Osteoporosis Therapeutics

Stoch, S. A., Chorev, M., & Rosenblatt, M. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50080-5

Studies of Interactions Between Myeloma Cells and Osteoblasts: In Vitro

Karadağ, A. (2019) · OpenGrey (Institut de l'Information Scientifique et Technique)

Stress Conditioning and Heat Shock Protein Manipulation for Bone Tissue Engineering

Chung, E. (2010) · VTechWorks (Virginia Tech)

Malignancies of the Bone

Crawford, M. R., Williams, S. E., Khan, L. Z., & Licata, A. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-03694-2_15

New Approaches to Osteoporosis Therapeutics

Dresner–Pollak, R., Stoch, S. A., & Rosenblatt, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50082-3

Mechanisms of Estrogen Action in Bone

Pacifici, R. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50141-4

Review The role of the bone marrow microenvironment in multiple myeloma

Vanderkerken, K. (2005)

Bones and Rheumatology

Abdulkhaliq, A. A. (2021) · Springer eBooks · doi:10.1007/978-981-15-8323-0_10

Transforming growth factor-β and its signaling pathway in skeletal complications of malignancy

Juárez, P., Iduarte, B. I., & Fournier, P. G. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00071-2

The Osteoclast

Chambers, T. J. (2003) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-55742-2_19

The Role of Purinergic Signaling in the Interactions between Skeletal Cells

Gartland, A., Gallagher, J. A., & Buckley, K. (2006) · CRC Press eBooks · doi:10.1201/9781420005059.ch3

p-Smad3 differentially regulates the cytological behavior of osteoclasts before and after osteoblasts maturation

Ye, J., Hua, Z., Xiao, J., Shao, Y., Li, S., Yin, H., Wu, M., Rong, Y., Hong, B., Guo, Y., et al. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09400-0

Role of Transforming Growth Factor Beta 1 in Reducing Orthodontic Relapse: Rabbit Model Study

Zubaidi, S. H. A., Alsaleem, N. R., & AlKataan, M. A. A. (2024) · Asian Journal of Dairy and Food Research · doi:10.18805/ajdfr.drf-401

Spécialisation fonctionnelle des sous-populations de cellules dendritiques plasmacytoïdes chez le rat

Anjubault, T. (2010)

TLR4-dependent upregulation of IL-22-producing T cells in the bone niche links to the imbalance of bone homeostasis

Kim, J.-E., Go, J., Lee, E.-J., Kim, S.-M., Jung, D., No, H., Hyun, M., Lee, Y.-J., Sung, Y., Ju, M. K., et al. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-026-00994-w

Osteogenic differentiation of gingival and periodontal ligament fibroblasts inhibits osteoclast formation in 2D and 3D fibrin cultures

Ceylan, M., de Vries, T. J., Runderkamp, W. J. A. M., Jansen, I. D. C., Schimmel, I. M., Picavet, D. I., Laine, M. L., & Schoenmaker, T. (2026) · Bone Reports · doi:10.1016/j.bonr.2026.101940

Transforming Growth Factor-β1 Increases mRNA Levels of Osteoclastogenesis Inhibitory Factor in Osteoblastic/Stromal Cells and Inhibits the Survival of Murine Osteoclast-like Cells

Murakami, T., Yamamoto, M., Yamamoto, M., Ono, K., Nishikawa, M., Nagata, N., Motoyoshi, K., & Akatsu, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9723 · Cited by 195

16. Lack of antagonist activity of melanocyte-stimulating hormone (MSH) on the actions of IL-1 on human bone-derived osteoblast-like cells

Evans, D., Thavarajah, M., & Kanis, J. A. (1991) · Bone · doi:10.1016/8756-3282(91)90112-v

Stimulation of Osteoprotegerin (OPG) Gene Expression by Transforming Growth Factor-β (TGF-β)

Thirunavukkarasu, K., Miles, R. R., Halladay, D., Yang, X., Galvin, R. J. S., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104319200 · Cited by 142

Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

Hofbauer, L. C., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., Riggs, B. L., & Khosla, S. (1999) · Bone · doi:10.1016/s8756-3282(99)00162-3 · Cited by 630

Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis in Vitro1

Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201